References
- Stokes EK, Zambrano LD, Anderson KN, et al. Coronavirus disease 2019 case surveillance - United States, January 22-May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(24):759–765.
- Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area [published correction appears in JAMA. 2020 May 26;323:2098]. JAMA. 2020;323(20):2052–2059.
- Tan E, Song J, Deane AM, et al. Global impact of coronavirus disease 2019 infection requiring admission to the ICU: a systematic review and meta-analysis. Chest. 2021;159(2):524–536.
- Cypel M, Keshavjee S. When to consider lung transplantation for COVID-19. Lancet Respir Med. 2020;8(10):944–946.
- Bharat A, Machuca TN, Querrey M, et al. Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries. Lancet Respir Med. 2021;9(5):487–497.
- Guidance from the international society of heart and lung transplantation regarding the SARS CoV-2 pandemic. cited 2022 Jan 17. ishlt.org/ishlt/media/documents/SARS-CoV-2_Guidance-for-Cardiothoracic-Transplant-and-VAD-center.pdf
- Attaway AH, Scheraga RG, Bhimraj A, et al. Severe covid-19 pneumonia: pathogenesis and clinical management. BMJ. 2021;372:n436.
- Dreier E, Malfertheiner MV, Dienemann T, et al. ECMO in COVID-19-prolonged therapy needed? A retrospective analysis of outcome and prognostic factors. Perfusion. 2021;36(6):582–591.
- Schmidt M, Hajage D, Lebreton G, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study. Lancet Respir Med. 2020;8(11):1121–1131.
- Kurihara C, Manerikar A, Gao CA, et al. Outcomes after extracorporeal membrane oxygenation support in COVID-19 and non-COVID-19 patients [published online ahead of print, 2021 Oct 25]. Artif Organs. 2022;46(4):688–696.
- Mohanka MR, Joerns J, Lawrence A, et al. ECMO Long-haulers: a distinct phenotype of COVID-19 associated ARDS with implications for lung transplant candidacy. [published online ahead of print, 2022 Feb 7]. Transplantation. 2022;106(4):E202–E211.
- King CS, Mannem H, Kukreja J, et al. Lung Transplantation for Patients With COVID-19. Chest. 2022;161(1):169–178.
- Shafran N, Shafran I, Ben-Zvi H, et al. Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients. Sci Rep. 2021;11(1):12703.
- Türk MS, Akarsu I, Tombul I, et al. The analysis of pleural complications of COVID-19 pneumonia. Turk J Med Sci. 2021;51(6):2822–2826.
- Lazzeri C, Bonizzoli M, Batacchi S, et al. Persistent right ventricle dilatation in SARS-CoV-2-related acute respiratory distress syndrome on extracorporeal membrane oxygenation support [published online ahead of print, 2021 Aug 21]. J Cardiothorac Vasc Anesth. 2021;36(7):1956–1961.
- Maharaj V, Alexy T, Agdamag AC, et al. Right ventricular dysfunction is associated with increased mortality in patients requiring venovenous extracorporeal membrane oxygenation for coronavirus disease 2019. ASAIO. 2022;Publish Ahead of Print: https://doi.org/10.1097/MAT.0000000000001666.
- Banga A, Batchelor E, Mohanka M, et al. Predictors of outcome among patients on extracorporeal membrane oxygenation as a bridge to lung transplantation. Clin Transplant. 2017;31(7):https://doi.org/10.1111/ctr.12990.